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Entomologic and Serologic 
Evidence of Zoonotic 
Transmission of Babesia 
microti, Eastern Switzerland
Ivo M. Foppa,* Peter J. Krause,† Andrew Spielman,* Heidi Goethert,* Lise Gern,‡ 
Brigit Brand,§ and Sam R. Telford III*
We evaluated human risk for infection with Babesia microti at a site in eastern Switzerland where several
B. microti–infected nymphal Ixodes ricinus ticks had been found. DNA from pooled nymphal ticks amplified
by polymerase chain reaction was highly homologous to published B. microti sequences. More ticks car-
ried babesial infection in the lower portion of the rectangular 0.7-ha grid than in the upper (11% vs. 0.8%).
In addition, we measured seroprevalence of immunoglobulin (Ig) G antibodies against B. microti antigen in
nearby residents. Serum from 1.5% of the 396 human residents of the region reacted to B. microti antigen
(>1:64), as determined by indirect immunofluorescence assay (IgG). These observations constitute the
first report demonstrating B. microti in a human-biting vector, associated with evidence of human exposure
to this agent in a European site.
 malaria-like syndrome due to Babesia microti infection
has been recognized in parts of the northeastern United
States for more than three decades (1,2). This protozoon
pathogen was first isolated more than half a century earlier
from a Portuguese vole (3); the pathogen has since been
detected in small mammals and ticks throughout Eurasia (3,4). 
Despite its broad geographic distribution, B. microti has
not been implicated as a cause of human illness in Europe. A
host-specific, rodent-feeding tick, Ixodes trianguliceps, is
widely regarded as the main enzootic vector on that continent.
I. ricinus, the most common human-biting tick of Europe,
transmits the Lyme borreliosis spirochete, tick-borne encepha-
litis virus, the agent of human granulocytic ehrlichiosis, and B.
divergens, but I. ricinus was believed to be infected only occa-
sionally with B. microti (5). This vector-pathogen association
may account for the absence of human disease due to B.
microti (3,6). However, subadult I. ricinus ticks feed abun-
dantly on the reservoirs of B. microti, such as voles and mice,
and appear to be competent vectors for B. microti (7). In fact,
recent studies indicate that Swiss residents may have concur-
rent infection with the Lyme disease spirochete and B. microti
(8) and that the human population of certain parts of Germany
is exposed to B. microti (9).
Human exposure to B. microti may occur more often in
Europe than has been recognized. Accordingly, we assessed
the potential of zoonotic transmission in eastern Switzerland,
where other I. ricinus–transmitted infections are present. In
particular, we determined how frequently B. microti parasites
infect I. ricinus ticks locally, how infection in ticks is spatially
distributed, and how frequently the sera of nearby residents
react to B. microti antigen.
Methods
Tick Collection and B. microti Detection in Ticks
To assess local prevalence of B. microti in host-seeking
nymphal I. ricinus ticks, we developed a tick-sampling proce-
dure with high spatial resolution (Figure 1). The roughly rec-
tangular, 0.7-ha field site, Ruetiwis (9° 38´ E, 46° 59´ N), is
located on a steep southwesterly slope near Seewis in the
lower Praettigau Valley of eastern Switzerland at an approxi-
mate mean altitude of 850 m above sea level. The site is char-
acterized by abandoned pastures that are partly overgrown by
young stands of deciduous and coniferous trees and bushes, as
well as by mature mixed forest. All ticks were collected by
flagging in July 1997. 
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A
Figure 1. Schematic drawing of the sampling scheme. Distance
between sampling points is 30 m. The letters and solid arrows denote
the sections used for prevalence estimation. Sampling lines that con-
nect points not belonging to a section are not included in that section
(e.g., line B4–C2 is not part of section B).Emerging Infectious Diseases  •  Vol. 8, No. 7, July 2002 723
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To ensure the quality of tick-derived DNA, pools of 2–11
nymphal ticks were transferred to 0.5-mL microcentrifuge
tubes containing 50 µL guanidium thiocyanate solution and
stored at room temperature until further processing. Before
homogenization with a glass pestle, the solution containing the
ticks was incubated at 60°C for 2 h. DNA was extracted from
the tick homogenate by the phenol-chloroform method. The
resulting DNA pellet was suspended in 30 µL DNAse-free
H20.
To determine whether B. microti–specific DNA was
present, the extracted DNA was subjected to polymerase chain
reaction (PCR) with the primer pair Bab-1 (5´-ttagtataagcttt-
tatacagc-3´) and Bab-4 (5´-ataggtcagaaacttgaatgataca-3´) (10),
which targets a 250-bp fragment of the 18s rRNA gene of B.
microti. After denaturation for 2 min at 94°C, 40 cycles were
performed, with 45 sec at 94°C, 45 sec at 55°C, and 45 sec at
72°C, followed by a 7-min final extension. Amplification
products were separated on 2% agarose gel in Tris-borate-
EDTA buffer, stained with ethidium bromide, and visualized
under UV light. To differentiate the sequence of interest from a
frequently observed, slightly smaller fragment, purified PCR
products were digested with XhoI (Life Technologies, Invitro-
gen Corp., Gaithersburg, MD). The resulting two fragments
specific for B. microti migrate in one band on the 2% agarose
gel. The corresponding sequence of B. divergens lacks the
restriction site. 
To verify the taxonomic status of the Babesia spp. detected
in these ticks, we conducted a phylogenetic analysis on a rep-
resentative sample from which DNA had been amplified (Bab-
1/Bab-4). For this purpose we used the primer pair PIRO A
and PIRO B, which also targets 18s rDNA but is less specific
for B. microti; the resulting sequence is longer (400 bp) than
the Bab-1/Bab-4 amplicon (11). After PCR amplification, the
respective band was excised from the agarose gel, purified
with spin columns (Qiagen Inc., Valencia, CA), and sent to the
University of Maine sequencing facility for sequence analysis.
The resulting sequence was aligned against other Babesia spp.
listed in GenBank by using Clustal X and consecutive adjust-
ment visually. Phylogenetic analysis was performed by both
maximum parsimony (Swofford D. Phylogenetic analysis
using parsimony, PAUP*4b61; Sinauer Associates, Inc., Sun-
derland, MA) and neighbor-joining analyses (12) with Toxo-
plasma gondii (GenBank accession no. X68523) as outgroup.
Robustness of the nodes was assessed by bootstrap analysis
with 500 bootstrap replicates.
Data Analysis
To accurately estimate the local prevalence of B. microti
infection in I. ricinus ticks, we developed a maximum likeli-
hood method for point estimation as well as a method for cal-
culating confidence intervals. Briefly, the maximum likelihood
estimate (MLE) of the prevalence p is based on the likelihood
,           
              ,
where                                  , N– is the number of ticks in nega-
tive pools, J is the set of pool sizes with at least one positive
pool, and nj is the number of positive pools of size j. Test-
inversion bootstrap confidence intervals (13) were calculated
for the prevalence estimate. 
To determine whether infected ticks were clustered in the
study site, we tested the null hypothesis ß1=ß2=0  by the model 
        , where  
if the                 pool is from section C and  otherwise, and
          if the pool is from section D and                   otherwise.
If the large sample confidence interval around the MLEs of ß1,
ß2 or both does not include 0, evidence for clustering is
positive.
Serologic Survey
To determine whether humans may be exposed to B.
microti in the study area, we recruited 400 blood donors living
within 10 km of the field site for a serologic survey of tick-
borne zoonoses. Volunteers were recruited for this cross-sec-
tional seroprevalence study during blood drives from Decem-
ber 1997 to May 1998 in towns within a 10-km radius of the
study site. This protocol was approved by the Human Subjects
Committee of the Harvard School of Public Health (protocol
number 9712THEE). The sera of participants who gave their
written informed consent were tested by indirect immunofluo-
rescence assay (IFA) as described (14). Antigen slides were
prepared from erythrocytes of B. microti–infected hamsters
(the GI strain, originally derived from a Nantucket Island
patient). Sera were first screened by IFA at 1:64 dilution. A
panel of sera included all samples reactive in the screening test
for which enough serum was available, including samples with
borderline reactivity and representative controls. This panel
was coded and blindly retested for B. microti IFA at the Uni-
versity of Connecticut laboratories, which specialize in Babe-
sia serology. An IFA titer >1:64 was considered reactive. All
reactive sera were titrated to endpoint. 
Results
Tick Survey
To verify the identity of the amplified DNA, a phyloge-
netic analysis was performed. The sequence amplified from
our I. ricinus ticks, which was deposited in GenBank (acces-
sion no. AF494286), differed by l bp from the North American
B. microti sequence (GenBank accession no. AF231348) and
was identical with that of B. microti from Slovenia (GenBank
accession no. AF373332). Accordingly, our sequence clearly
clustered with the European and the American strain of B.
microti (Figure 2), with concordant results from both maxi-
mum parsimony and neighbor-joining analyses. Therefore, the
piroplasms detected in I. ricinus ticks from Switzerland must
be considered B. microti. 
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We then determined the prevalence of B. microti infection
in nymphal I. ricinus ticks from the study site, on the basis of
PCR amplification of B. microti in DNA tick pools. Overall,
we analyzed 408 ticks in 64 pools. We detected B. microti–
specific DNA in 14 pools (Table 1). Thus, B. microti infection
appears to be common in human-biting ticks at this central
European study site.
To determine whether the prevalence of B. microti is dis-
tributed homogeneously within the study site, prevalence of
infection in ticks was estimated for selected segments of the
sampling grid. The overall prevalence of B. microti infection
in ticks, as estimated by MLE, was close to 4%. More detailed
spatial analysis, however, indicates that the distribution of
babesial infection at the site is heterogeneous (Table 2). In the
lower portion of the site (section D), >10% of all ticks were
infected, while in the upper portion (B–C), prevalence was
<1%. Prevalence of infection in ticks was similar in sections B
and C (p=0.161), but greater in section D than in sections B
and C (p=0.003). Thus, B. microti transmission is focal at this
site. 
Serologic Survey
To determine how frequently humans are exposed to B.
microti infection in the region around the study site, sera of
local residents were screened by IFA for the presence of anti-
bodies to B. microti antigen. Most sera (80%) were collected
from December through March, when I. ricinus is not active.
Five (1.5%) of 396 human sera were immunoglobulin (Ig) G-
reactive against B. microti antigen at a titer >1:64. All the sam-
ples positive on initial testing and one with a borderline result
were confirmed on retesting to be reactive at a titer >1:64,
while none of the samples with a negative screening result
reacted (Table 3). B. microti–specific IgM seroreactivity was
not found in any of the sera, a finding compatible with the time
of the year when most of the sera had been collected. These
results indicate that residents of our central European study
site are exposed to bites of ticks infected with B. microti.
Discussion
B. microti–infected nymphal I. ricinus ticks are present at
this Swiss study site, and human residents of the area appear to
Figure 2. Maximum parsimony bootstrap consensus tree of 18S rDNA.
GenBank accession nos.: Babesia microti-Slovenia AF373332; B.
microti-Switzerland AF494286; B. microti- Nantucket AF231348; "Toxo-
plasma annae" AF188001; B. rodhaini AB049999; WA1 AF158700; B.
gibsoni 1 AF158702; B. divergens 1 U07885; B. divergens 2 U16370;
B. odocoilei U16369; B. gibsoni 2 AF175300; B. gibsoni 3 AF175301;
and Toxoplasma gondii X68523.
Table 1. Babesia microti infection in nymphal Ixodes ricinus ticks as 
determined by polymerase chain reaction, eastern Switzerland 
Sampling 
point or line Pool 1 Pool 2 Pool 3 Pool 4 Pool 5
No. of 
pools
No. of 
ticks
B1 11 11 12 — — 3 34
B1–2 10 10 10 — — 3 30
B2 4 3 — — — 2 7
B2–3 3 3 3 — — 3 9
B3 3 — — — — 1 3
B3–4 8a 8— — —2 1 6
B4 1 — — — — 1 1
B4–C2 5 5 4 5 — 4 19
C1 1 — — — — 1 1
C1–2 9 9 9 9 — 4 36
C2 7 75 — — 31 9
C2–3 5 5 5 5 5 5 25
C3 10 — — — — 1 10
C3–4 4 — — — — 1 4
C4 4 — — — — 1 4
C4–5 7 6 — — — 2 13
C5 8 7 6 — — 3 21
C5–D1 8778—4 3 0
D1 556— —3 1 6
D1–2 8 7 — — — 2 15
D2 6 6 — — — 2 12
D2–3 5556652 7
D3 4 — — — — 1 4
D3–4 6 65 — — 31 7
D4 11 11 10 — — 3 32
D4–5 3 — — — — 1 3
D5 0 — — — — 0 0
Total 64 408
aPools in bold are positive; dashes represent the absence of further pools. Emerging Infectious Diseases  •  Vol. 8, No. 7, July 2002 725
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be exposed to this agent. However, the presence of B. microti
in I. ricinus ticks has been reported only rarely (5).
A phylogenetic analysis clearly demonstrated that the piro-
plasms found in our study site belong to B. microti, rather than
to other Babesia or Theileria species (Figure 2). The detection
of B. microti DNA in host-seeking nymphal I. ricinus ticks
may, however, simply reflect “spill-over” from enzootic trans-
mission by the accepted maintenance vector for B. microti in
Eurasia, the tick I. trianguliceps (15). This tick, which does
not bite humans, infests small rodents that also are abundantly
parasitized by I. ricinus (3,16). The prevalence of infection in
ticks may be underestimated as only one genome copy is
present per parasite in unfed ticks before sporogony. There-
fore, low parasite loads may escape detection, thus increasing
the specificity of the assay.
In our study, maximizing specificity was desirable because
infection of I. ricinus with B. microti was a priori assumed to
be rare, and underestimation of prevalence therefore is conser-
vative. Regardless, the proportion of ticks that appear to be
infected by B. microti is similar to that in coastal New England
(S. Telford, unpub. data). Recently, Duh et al. reported a simi-
larly high prevalence of B. microti infection in nymphal I. rici-
nus ticks collected in Slovenia (7 of 69 ticks tested by PCR)
(17). In combination with our findings, this report suggests
that B. microti infection in I. ricinus ticks is far more common
than traditionally thought. In addition, vector competence of I.
ricinus for B. microti has been demonstrated experimentally
(7,18). The frequent infection of I. ricinus with this piroplasm
therefore implies zoonotic relevance of this vector-pathogen
association in Switzerland and possibly in other parts of
Europe.
B. microti transmission is clustered in the study site. Simi-
lar to tick-borne encephalitis virus, B. microti seems to be
maintained in small focal areas. The risk of human infection
therefore is spatially highly variable and conditional on tick
density. Preliminary analysis of tick infection data from the
study site over a 3-year period (Foppa, unpub. data) suggests
that B. microti is locally maintained, especially in the lower
portion of that site, while the exact location of the maximum
risk changes over the years.
Residents of this region in eastern Switzerland appear to be
exposed to bites by ticks infected with B. microti. The sero-
logic result is unlikely to reflect low specificity of the assay, as
previous evaluation of this IFA has demonstrated high speci-
ficity (19,20). As part of this evaluation, we tested 50 sera
from residents of Iceland, where ticks capable of transmitting
B. microti are absent; none of the sera reacted with B. microti
antigen (19). We recently repeated testing of these sera and
obtained similar results. This finding suggests a satisfactory
positive predictive value of the serologic test even in settings
of low prevalence. 
In the northeastern United States, B. microti seropreva-
lence has varied in endemic regions, from 3.7% in Red Cross
blood donors on Cape Cod, Massachusetts (21), to 2.5% and
9.5% in Connecticut residents who were seronegative and
seroreactive, respectively, to Borrelia burgdorferi (22).  Our
findings of high local prevalence of B. microti infection in I.
ricinus ticks may seem counterintuitive given the lower sero-
prevalence in residents of our study area. The findings may,
however, reflect a high degree of spatial clustering of trans-
mission with a low average risk (18). Alternatively, the low
seroprevalence may be the result of low test sensitivity result-
ing from antigenic differences between North American B.
microti strains, which were used for the serologic testing, and
the European strains to which our study population had been
exposed.
At least locally, the potential for zoonotic transmission of
B. microti by I. ricinus is considerable, which explains sero-
logic evidence in human beings of exposure to this agent in
parts of Europe. The lack of recognized human pathology
associated with European strains of B. microti, despite expo-
sure to infectious tick bites, may be a consequence of a lower
virulence of European strains than those of North American.
Disease episodes due to B. microti, on the other hand, may be
overlooked because of the relative nonspecificity of signs and
symptoms and the presumption that this agent rarely infects I.
ricinus.
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Table 2. Global and local prevalence estimates of Babesia microti 
infection in nymphal Ixodes ricinus ticks as determined by polymerase 
chain reaction, eastern Switzerland 
Point estimate (%) 95% confidence interval
MLEa, overall 3.6 0.2 to 9.06
MLE, section B 1.04 0.10 to 9.01
MLE, section C 0.77 0.08 to 8.47
MLE, section D 10.99 6.17 to 17.71
MLE, sections B,C 0.82 0.61 to 2.65
MLE, sections C,D 5.25 2.96 to 10.43
aMLE (maximum likelihood estimate) of the point estimates are shown with 95% boot-
strap confidence limits.
Table 3. Reactivity of sera tested against Babesia microti 
as determined by indirect immunofluorescent assay 
Titer No. of sera (%)
<1:64 391 (98.7)
1:64 1 (0.3)
1:128 1 (0.3)
1:256 1 (0.3)
1:512 2 (0.5)
Total 396 (100.0)RESEARCH
726 Emerging Infectious Diseases  •  Vol. 8, No. 7, July 2002
Dr. Foppa is assistant professor of epidemiology at the Norman J.
Arnold School of Public Health, University of South Carolina,
Columbia. His main interests include quantitative methods in infec-
tious disease epidemiology and dynamics of vector-borne zoonoses.
References
1. Spielman A. Human babesiosis on Nantucket Island: transmission by
nymphal Ixodes ticks. Am J Trop Med Hyg 1976;25:784–7.
2. Spielman A. The emergence of Lyme disease and human babesiosis in a
changing environment. Ann N Y Acad Sci 1994;740:146–56.
3. Sebek Z, Rosicky B, Sixl W. The occurrence of babesiasis affecting small
terrestrial mammals and the importance of this zoonosis in Europe. Folia
Parasitol 1977;24:221–8.
4. Telford SR, Gorenflot A, Brasseur P, Spielman A. Babesial infections in
humans and wildlife. In: Kreier JP, editor. Parasitic protozoa. Vol. 5. New
York: Academic Press; 1993. p. 1–47.
5. Walter G. Isolierung von Babesia microti (Franca 1912) aus freilebenden
Nymphen von Ixodes ricinus (Linnaeus 1758). Acta Trop 1981;38:187–8.
6. Hussein HS. Ixodes trianguliceps: seasonal abundance and role in the epi-
demiology of Babesia microti infection in north-western England. Ann
Trop Med Parasitol 1980;74:531–9.
7. Gray J, von Stedingk LV, Gurtelschmid M, Granstrom M. Transmission
studies of Babesia microti in Ixodes ricinus ticks and gerbils. J Clin
Microbiol 2002;40:1259–63.
8. Mehr-Scherrer L. Babesia-Infektionen nun auch in der Schweiz? Bulletin
of the Swiss Federal Office of Public Health 1999;978–9.
9. Hunfeld KP, Allwinn R, Peters S, Kraiczy P, Brade V. Serologic evidence
for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in
Lyme borreliosis patients from midwestern Germany. Wien Klin Wochen-
schr 1998;110:901–8.
10. Persing DH, Mathiesen D, Marshall WF, Telford SR, Spielman A, Thom-
ford JW, et al. Detection of Babesia microti by polymerase chain reaction.
J Clin Microbiol 1992;30:2097–103.
11. Armstrong PM, Katavolos P, Caporale DA, Smith RP, Spielman A, Tel-
ford SR. Diversity of Babesia infecting deer ticks (Ixodes dammini). Am
J Trop Med Hyg 1998;58:739–42.
12. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: molecular evolution-
ary genetics analysis software. Bioinformatics 2001;17:1244–5.
13. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which,
what? A practical guide for medical statisticians. Stat Med
2000;19:1141–64.
14. Krause PJ, Telford SR, Pollack RJ, Ryan R, Brassard P, Zemel L, et al. A.
Babesiosis: an underdiagnosed disease of children. Pediatrics
1992;89:1045–8.
15. Randolph SE. Quantifying parameters in the transmission of Babesia
microti by the tick Ixodes trianguliceps amongst voles (Clethrionomys
glareolus). Parasitology 1995;110:287–95.
16. Gern L, Aeschlimann A. Etude seroepidemiologique de 2 foyers a babe-
sie de micromammiferes en Suisse. Schweiz Arch Tierheilkd
1986;128:587–600.
17. Duh D, Petrovec M, Avsic-Zupanc T. Diversity of Babesia infecting
European sheep ticks (Ixodes ricinus). J Clin Microbiol 2001;39:3395–7.
18. Telford SR, Urioste SS, Spielman A. Clustering of host-seeking nymphal
deer ticks (Ixodes dammini) infected by Lyme disease spirochetes (Borre-
lia burgdorferi). Am J Trop Med Hyg 1992;47:55–60.
19. Krause PJ, Telford SR, Ryan R, Conrad PA, Wilson M, Thomford JW, et
al. Diagnosis of babesiosis: evaluation of a serologic test for the detection
of Babesia microti antibody. J Infect Dis 1994;169:923–6.
20. Krause PJ, Ryan R, Telford S, Persing D, Spielman A. Efficacy of immu-
noglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis. J
Clin Microbiol 1996;34:2014–6.
21. Popovsky MA, Lindberg LE, Syrek AL, Page PL. Prevalence of Babesia
antibody in a selected blood donor population. Transfusion 1988;28:59–
61.
22. Krause PJ, Telford SR, Ryan R, Hurta AB, Kwasnik I, Luger S, et al.
Geographical and temporal distribution of babesial infection in Connecti-
cut. J Clin Microbiol 1991;29:1–4.
Address for correspondence: Ivo M. Foppa, Department of Epidemiology and
Biostatistics, Norman J. Arnold School of Public Health, 800 Sumter Street,
Columbia, SC 29208, USA; fax: 803-777-2524; e-mail: ifoppa@sc.edu
OPPORTUNITIES FOR PEER REVIEWERS
The editors of Emerging Infectious Diseases seek to
increase the roster of reviewers for manuscripts submitted by
authors all over the world for publication in the journal. If you
are interested in reviewing articles on emerging infectious dis-
ease topics, please e-mail your name, address, qualifications or
curriculum vitae, and areas of expertise to eideditor@cdc.gov 
At Emerging Infectious Diseases, we always request
reviewers’ consent before sending manuscripts, limit review
requests to three or four per year, and allow 2-4 weeks for com-
pletion of reviews. We consider reviewers invaluable in the pro-
cess of selecting and publishing high-quality scientific articles
and acknowledge their contributions in the journal once a year. 
Even though it brings no financial compensation, partici-
pation in the peer-review process is not without rewards. Manu-
script review provides scientists at all stages of their career
opportunities for professional growth by familiarizing them
with research trends and the latest work in the field of infec-
tious diseases and by improving their own skills for presenting
scientific information through constructive criticism of those of
their peers. To view the spectrum of articles we publish, infor-
mation for authors, and our extensive style guide, visit the jour-
nal web site at www.cdc.gov/eid .
For more information on participating in the peer-review pro-
cess of Emerging Infectious Diseases, e-mail eideditor@cdc.gov
or call the journal office at 404-371-5329.
Another Dimension. Thoughtful essays, short sto-
ries, or poems on philosophical issues related to science,
medical practice, and human health. Topics may include
science and the human condition, the unanticipated side
of epidemic investigations, or how people perceive and
cope with infection and illness. This section is intended
to evoke compassion for human suffering and to expand
the science reader's literary scope. Manuscripts are
selected for publication as much for their content (the
experiences they describe) as for their literary merit.
Another Dimension articles in previous issues
http://www.cdc.gov/ncidod/eid/vol6no1/myrianthopoulos.htm
http://www.cdc.gov/ncidod/eid/vol7no3_supp/stone.htm
http://www.cdc.gov/ncidod/EID/vol8no2/01-0513.htm
http://www.cdc.gov/ncidod/EID/vol8no2/01-0513-b.htm